arrow_back Back to App

Request for Information on COVID-19 IP Waiver Impact

This document is a request to the U.S. President to provide information regarding the waiver of intellectual property rights for COVID-19 vaccines and treatments. It aims to assess whether such actions will genuinely increase global supply and delivery, and if China will be prevented from accessing sensitive technologies. For citizens, this means an effort to understand if government policy is effectively combating the pandemic and protecting national interests.
Key points
The request seeks documents and data on the impact of waiving intellectual property rights on global availability of COVID-19 vaccines and treatments.
The goal is to verify if such a waiver will accelerate the end of the pandemic and if China will be prevented from accessing key technologies.
The document aims to increase transparency in government decisions regarding pandemic response and intellectual property protection.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_1285
Sponsor: Rep. Smith, Adrian [R-NE-3]
Process start date: 2022-07-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1285.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-26.

What are the main provisions?

Key points include:

  • The request seeks documents and data on the impact of waiving intellectual property rights on global availability of COVID-19 vaccines and treatments.
  • The goal is to verify if such a waiver will accelerate the end of the pandemic and if China will be prevented from accessing key technologies.
  • The document aims to increase transparency in government decisions regarding pandemic response and intellectual property protection.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Smith, Adrian [R-NE-3].

What is the latest detailed status?

The latest detailed status is: Placed on the House Calendar, Calendar No. 127.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Courts and Law Economy